Patents by Inventor Philbert Ip

Philbert Ip has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GPC3 T CELL-ANTIGEN COUPLERS AND USES THEREOF
    Publication number: 20250043021
    Abstract: GPC3 T cell antigen coupler (TAC) polypeptides having (i) an antigen-binding domain that binds GPC3, (ii) an antigen-binding domain that binds a protein associated with a TCR complex, and (iii) a T cell receptor signaling domain polypeptide are provided.
    Type: Application
    Filed: July 7, 2022
    Publication date: February 6, 2025
    Inventors: Andreas Bader, Christopher W. Helsen, Philbert Ip, Tania Benatar
  • CLAUDIN 18.2 T CELL-ANTIGEN COUPLERS AND USES THEREOF
    Publication number: 20240366763
    Abstract: Claudin 18.2 T cell antigen couplers (TACs) polypeptides having (i) an antigen-binding domain that binds Claudin 18.2, (ii) an antigen-binding domain that binds a protein associated with a TCR complex, and (iii) a T cell receptor signaling domain polypeptide are provided.
    Type: Application
    Filed: May 14, 2024
    Publication date: November 7, 2024
    Inventors: Andreas Bader, Christopher W. Helsen, Philbert Ip, Tania Benatar, Ling Wang
  • GUCY2C T CELL-ANTIGEN COUPLERS AND USES THEREOF
    Publication number: 20240252643
    Abstract: GUCY2C T cell antigen coupler (TAC) polypeptides having (i) an antigen-binding domain that binds GUCY2C, (ii) an antigen-binding domain that binds a protein associated with a TCR complex, and (iii) a T cell receptor signaling domain polypeptide are provided.
    Type: Application
    Filed: June 30, 2022
    Publication date: August 1, 2024
    Inventors: Andreas Bader, Christopher W. Helsen, Philbert Ip, Tania Benatar
  • Claudin 18.2 T cell-antigen couplers and uses thereof
    Patent number: 12016923
    Abstract: Claudin 18.2 T cell antigen couplers (TACs) polypeptides having (i) an antigen-binding domain that binds Claudin 18.2, (ii) an antigen-binding domain that binds a protein associated with a TCR complex, and (iii) a T cell receptor signaling domain polypeptide are provided. Nucleic acids encoding the claudin 18/2 TACs are also provided.
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: June 25, 2024
    Assignee: Triumvira Immunologics USA, Inc.
    Inventors: Andreas Bader, Christopher W. Helsen, Philbert Ip, Tania Benatar, Ling Wang
  • CLAUDIN 18.2 T CELL-ANTIGEN COUPLERS AND USES THEREOF
    Publication number: 20230364237
    Abstract: Claudin 18.2 T cell antigen couplers (TACs) polypeptides having (i) an antigen-binding domain that binds Claudin 18.2, (ii) an antigen-binding domain that binds a protein associated with a TCR complex, and (iii) a T cell receptor signaling domain polypeptide are provided. Nucleic acids encoding the claudin 18/2 TACs are also provided.
    Type: Application
    Filed: June 1, 2022
    Publication date: November 16, 2023
    Inventors: Andreas Bader, Christopher W. Helsen, Philbert Ip, Tania Benatar, Ling Wang